Navigation Links
Cellectricon and AstraZeneca - Partners in New High Throughput Ion Channel Drug Discovery Technology
Date:6/11/2008

GOTHENBURG, Sweden, June 11 /PRNewswire/ -- Cellectricon, a leading provider of screening solutions for drug discovery, today announced a new collaborative agreement with AstraZeneca. Under the agreement Cellectricon will provide AstraZeneca with two of its new groundbreaking high throughput platform, Dynaflow(R)HT, for ion channel screening.

Cellectricon and AstraZeneca formed and announced a collaboration in May 2006 aiming to find a solution to major bottlenecks in ligand gated ion channel screening. The results from this collaboration have successfully demonstrated the unique performance of Cellectricon's cell-based microfluidic screening platform. It has clearly demonstrated the opportunity to introduce the fully automated Dynaflow(R)HT System with unmatched level of stability and throughput while still delivering unique measurement data quality. The Dynaflow(R)HT System will be launched and commercially available in 2009.

"Collaborating with AstraZeneca has been most rewarding," says Jonas Ohlsson, CEO at Cellectricon. "Driven by solving bottlenecks in drug discovery, Cellectricon's strategy is to bring state-of-the-art products for drug discovery and research to the market through world-class customer collaborations."

"This collaboration aims to accelerate our efforts in ion channel drug discovery and has been very fruitful to date. We look forward to working with the Dynaflow@HT Systems and see the impact of their throughput and cost effectiveness," says Dr. Jan-Erik Nystrom, VP Local Discovery Research Area CNS & Pain Control, Sodertalje, Sweden.

"The strength of this platform is that it is based on many years of cutting-edge academic and industrial research in ion channel drug discovery. I am happy to see us taking a new step together with a leading partner in advancing it further," says Dr. Jon Sinclair, VP Research & Development at Cellectricon.

About Cellectricon

Cellectricon AB (

SOURCE Cellectricon AB
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Share Issue Gives Cellectricon SEK 89 Million to Continue its Rapid Market Expansion
2. Pediatric Asthma Programs Featuring PARI Pharmas eFlow Acquired by AstraZeneca
3. AstraZeneca Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Into MedImmune
4. AstraZeneca and Banner Alzheimers Institute Collaborate to Evaluate New Tool Targeting Alzheimers Disease
5. Epistem plc and AstraZeneca Complete Plucked Hair Biomarker Study for Oncology Drug Development
6. Meditrina Pharmaceuticals, Inc. Announces Exclusive Global License Agreement With AstraZeneca
7. AstraZeneca Response to February 21, 2008 Ruling In Re: Alabama Medicaid Pharmaceutical AWP Litigation - cv2005-219 - Circuit Court of Montgomery, Alabama
8. AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder
9. AstraZeneca Completes Enrollment in Two Pivotal Phase III Studies of the Investigational Drug Vandetanib (ZACTIMA(R)) in Non-Small Cell Lung Cancer (NSCLC)
10. Silence Therapeutics and AstraZeneca Announce Collaboration to Develop Novel Approaches for siRNA Drug Delivery
11. AstraZenecas Zactima to Earn Almost Five Percent Patient Share in the Treatment of Non-Small-Cell Lung Cancer by 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... May 05, 2015 The Academy of ... of Indiana, led by Indiana Gov. Mike Pence, has ... AMA Foundation will host a Family Fest and aviation ... proceeds will benefit the Wounded Warrior Project. , National ... of Model Aeronautics—the country’s foremost organization for model aviation—to ...
(Date:5/5/2015)... -- A group of biotechnology executives and medical doctors announced ... non-profit organization dedicated to providing education, research and therapeutic ... consciousness.  ... Coma is the ... actions can be initiated by the patient, and sleep-wake ...
(Date:5/5/2015)... , May 05, 2015 Research and ... the addition of the "Clinical Laboratory, Molecular ... Forecasts 2015 to 2019 - Europe Version" ... developments especially in the area of molecular diagnostics ... growing and evolving world market that is moving ...
(Date:5/5/2015)... MI (PRWEB) May 05, 2015 ... Parker Hannifin distributor, announces the launch of ... fleet operators with a convenient way to purchase ... maintenance products . , The new website ... 100,000 vehicles with direct access to high performance ...
Breaking Biology Technology:State of Indiana proclaims August 15 as Model Aviation Day 2Biotechnology Executives and Medical Doctors Team Up to Tackle Coma and Disorders of Consciousness 2Biotechnology Executives and Medical Doctors Team Up to Tackle Coma and Disorders of Consciousness 3Biotechnology Executives and Medical Doctors Team Up to Tackle Coma and Disorders of Consciousness 4Biotechnology Executives and Medical Doctors Team Up to Tackle Coma and Disorders of Consciousness 5European Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market 2015-2019 2Exotic Automation & Supply Launches Ecommerce Website 2
... Sept. 13 The Convergent Procedure, a novel ... epicardial ablation products from nContact Surgical, Inc. (nContact), ... of the EACTS (European Association for Cardio-Thoracic Surgery) ... medical professionals attended the 2010 Techno-College Programme to ...
... MOUNTAIN VIEW, Calif., Sept. 10 VIVUS, Inc. (Nasdaq: ... will present an overview of the company at four ... presentation schedule is as follows:Bank of America Merrill Lynch ... officerSeptember 16, 2010 at 2:30 p.m. BST Bank of ...
... 10 Paratek Pharmaceuticals, Inc. today announced the ... will be the subject of several poster presentations ... and Chemotherapy (ICAAC).  Dr. Stuart Levy, co-founder and ... delivering a talk at a symposium on antibiotic ...
Cached Biology Technology:The Convergent Procedure for the Treatment of Chronic Atrial Fibrillation Highlighted at EACTS Annual Meeting in Geneva 2VIVUS to Present at Four Upcoming Investor Conferences 2Paratek to Present Clinical Data at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy 2Paratek to Present Clinical Data at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy 3
(Date:4/9/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ), a ... it will report financial results for the third quarter ... the close of market. The company will host a ... p.m. PT (5:00 p.m. ET), during which management may ... the live call, analysts and investors should dial 888-438-5524 ...
(Date:4/2/2015)... , April 2, 2015 According ... 2015 attributed to somewhat higher than 125 MSEK. This ... year-end report 2014 that revenues for Q1 2015 would ... company reported for Q4 2014. The operating result for ... negative. The complete interim report will as previously communicated ...
(Date:3/31/2015)... NEW YORK , March 31, 2015   ... announced the launch of the Post-Surgical Pain Management TRACKER, ... data products tracking usage trends in the medical device ... monthly access to data including treatment volumes, market share, ... manage the pain associated with joint surgery. ...
Breaking Biology News(10 mins):Synaptics to Report Third Quarter Results on April 23 2Fingerprint Cards Revises Revenues for Q1 2015 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3
... A report published today concludes that the African lion is ... African lion once ranged continuously from Senegal to Nigeria, but ... 250 adult lions restricted to four isolated and severely imperiled ... lions. Led by Panthera,s Lion Program Survey ...
... the Fukushima 1 Nuclear Power Plant in 2011, Japanese plant ... contamination on wild and cultivated plants. In a special issue ... examine the potential adverse effects of radioactivity on nature and ... on the efforts of a research group led by Yoshihiro ...
... Tobacco smoking by pregnant women has long been ... adverse effects on the development of a fetus. ... outcomes, including low birth weight, sudden infant death syndrome, ... and nicotine use in offspring. Despite this extensive literature, ...
Cached Biology News:Lions are critically endangered in West Africa 2Lions are critically endangered in West Africa 3Microalgae and aquatic plants can help to decrease radiopollution in the Fukushima area 2Maternal stress hormones and maternal smoking increase daughter's risk of nicotine dependence 2